Jia DD - Search Results

1

Mutational profiling of melanomas in patients from the southeast coast of China.

Zheng AW, Jia DD, Zhou CC, Li T. Zheng AW, et al. Among authors: jia dd. Transl Cancer Res. 2020 Aug;9(8):4781-4789. doi: 10.21037/tcr-20-1871. Transl Cancer Res. 2020. PMID: 35117841 Free PMC article.

2

Impact of carboplatin plus paclitaxel combined with endostar against A375 melanoma cells: An in vitro and in vivo analysis.

Zheng AW, Jia DD, Xia LM, Jin G, Wu H, Li T. Zheng AW, et al. Among authors: jia dd. Biomed Pharmacother. 2016 Oct;83:1321-1326. doi: 10.1016/j.biopha.2016.08.047. Epub 2016 Aug 27. Biomed Pharmacother. 2016. PMID: 27571875

3

Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.

Zheng AW, Chen YQ, Fang J, Zhang YL, Jia DD. Zheng AW, et al. Among authors: jia dd. Biomed Pharmacother. 2017 May;89:1172-1177. doi: 10.1016/j.biopha.2017.03.012. Epub 2017 Mar 14. Biomed Pharmacother. 2017. PMID: 28320083

4

Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.

Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC. Jin G, et al. Among authors: jia dd. Med Sci Monit. 2018 Apr 26;24:2569-2577. doi: 10.12659/MSM.909651. Med Sci Monit. 2018. PMID: 29698379 Free PMC article.

5

PD-L1⁺ regulatory B cells act as a T cell suppressor in a PD-L1-dependent manner in melanoma patients with bone metastasis.

Wu H, Xia L, Jia D, Zou H, Jin G, Qian W, Xu H, Li T. Wu H, et al. Mol Immunol. 2020 Mar;119:83-91. doi: 10.1016/j.molimm.2020.01.008. Epub 2020 Jan 27. Mol Immunol. 2020. PMID: 32001420

6

Adjuvant pembrolizumab versus high-dose interferon α-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study.

Li T, Jia DD, Teng LS. Li T, et al. Among authors: jia dd. Invest New Drugs. 2020 Oct;38(5):1334-1341. doi: 10.1007/s10637-020-00913-6. Epub 2020 Feb 18. Invest New Drugs. 2020. PMID: 32072356

7

Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma.

Jia DD, Niu Y, Zhu H, Wang S, Ma T, Li T. Jia DD, et al. Front Oncol. 2021 Jun 16;11:675873. doi: 10.3389/fonc.2021.675873. eCollection 2021. Front Oncol. 2021. PMID: 34221994 Free PMC article.

8

METTL3-induced UCK2 m⁶A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway.

Wu H, Xu H, Jia D, Li T, Xia L. Wu H, et al. Ann Transl Med. 2021 Jul;9(14):1155. doi: 10.21037/atm-21-2906. Ann Transl Med. 2021. PMID: 34430596 Free PMC article.

9

Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.

Jin G, Wang C, Jia D, Qian W, Yin C, Wang D, Yang Q, Li T, Zheng A. Jin G, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211068964. doi: 10.1177/15330338211068964. Technol Cancer Res Treat. 2021. PMID: 34939467 Free PMC article.

10

Retrospective Review of Efficacy and Safety of Anlotinib in Advanced Leiomyosarcoma: A Real-World Study.

Zou H, Xia L, Jin G, Wu H, Qian W, Jia D, Xu H, Li T. Zou H, et al. Cancer Manag Res. 2022 May 11;14:1703-1711. doi: 10.2147/CMAR.S357334. eCollection 2022. Cancer Manag Res. 2022. PMID: 35585940 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters